![](/img/cover-not-exists.png)
8-4 - Genomics and CNS at Merck KGaA: first year evaluation; goals and prospects
I. den Daas, C.A. Seyfried, C.J. Schmitges, I. LuesVolume:
42
Year:
1997
Language:
english
DOI:
10.1016/s0006-3223(97)86906-5
File:
PDF, 267 KB
english, 1997